Skip to main content

Use of Inhibitory Compounds to Dissect the Molecular Pathways Involved in Regulatory B-Cell Differentiation

  • Protocol
  • First Online:
Regulatory B Cells

Part of the book series: Methods in Molecular Biology ((MIMB,volume 2270))

  • 1378 Accesses

Abstract

Regulatory B cells (Bregs) are IL-10-producing lymphocytes able to suppress inflammatory and autoimmune responses. Pharmacological inhibition of key enzymes within metabolic or signaling pathways enables the identification of factors involved in the differentiation and function of Bregs . Isolation and treatment of splenic B cells derived from IL-10 reporter mice allow fast screening for modulatory compounds influencing IL-10 secretion via flow cytometry. In this chapter, we outline the protocol for the induction of highly potent and metabolically active Bregs using the short-chain fatty acid pentanoate. Moreover, we show how the utilization of inhibitory compounds facilitates the dissection of the engaged pathways in Bregs .

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Protocol
USD 49.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Peng B, Ming Y, Yang C (2018) Regulatory B cells: the cutting edge of immune tolerance in kidney transplantation. Cell Death Dis 9(2):109. https://doi.org/10.1038/s41419-017-0152-y

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Evans JG, Chavez-Rueda KA, Eddaoudi A et al (2007) Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 178(12):7868–7878. https://doi.org/10.4049/jimmunol.178.12.7868

    Article  CAS  PubMed  Google Scholar 

  3. Yanaba K, Bouaziz J-D, Haas KM et al (2008) A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 28(5):639–650. https://doi.org/10.1016/j.immuni.2008.03.017

    Article  CAS  PubMed  Google Scholar 

  4. Yoshizaki A, Miyagaki T, DiLillo DJ et al (2012) Regulatory B cells control T-cell autoimmunity through IL-21-dependent cognate interactions. Nature 491(7423):264–268. https://doi.org/10.1038/nature11501

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Bankó Z, Pozsgay J, Szili D et al (2017) Induction and Differentiation of IL-10-Producing Regulatory B Cells from Healthy Blood Donors and Rheumatoid Arthritis Patients. J Immunol 198(4):1512–1520. https://doi.org/10.4049/jimmunol.1600218

    Article  CAS  PubMed  Google Scholar 

  6. Mion F, Tonon S, Toffoletto B, Cesselli D, Pucillo CE, Vitale G (2014) IL-10 production by B cells is differentially regulated by immune-mediated and infectious stimuli and requires p38 activation. Mol Immunol 62(2):266–276. https://doi.org/10.1016/j.molimm.2014.05.018

    Article  CAS  PubMed  Google Scholar 

  7. Suzuki-Yamazaki N, Yanobu-Takanashi R, Okamura T et al (2017) IL-10 production in murine IgM+ CD138hi cells is driven by Blimp-1 and downregulated in class-switched cells. Eur J Immunol 47(3):493–503. https://doi.org/10.1002/eji.201646549

    Article  CAS  PubMed  Google Scholar 

  8. Mishima Y, Oka A, Liu B et al (2019) Microbiota maintain colonic homeostasis by activating TLR2/MyD88/PI3K signaling in IL-10-producing regulatory B cells. J Clin Invest 130. https://doi.org/10.1172/JCI93820

  9. Luu M, Visekruna A (2019) Short-chain fatty acids: Bacterial messengers modulating the immunometabolism of T cells. Eur J Immunol 49(6):842–848. https://doi.org/10.1002/eji.201848009

    Article  CAS  PubMed  Google Scholar 

  10. Luu M, Pautz S, Kohl V et al (2019) The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes. Nat Commun 10(1):760. https://doi.org/10.1038/s41467-019-08711-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgments

We would like to thank the Studienstiftung des deutschen Volkes and the Von Behring-Röntgen-Stiftung for funding Maik Luu. Alexander Visekruna is funded by the German Research Foundation (startup grant from DFG-KFO325).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alexander Visekruna .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Science+Business Media, LLC, part of Springer Nature

About this protocol

Check for updates. Verify currency and authenticity via CrossMark

Cite this protocol

Luu, M., Visekruna, A. (2021). Use of Inhibitory Compounds to Dissect the Molecular Pathways Involved in Regulatory B-Cell Differentiation. In: Mion, F., Tonon, S. (eds) Regulatory B Cells. Methods in Molecular Biology, vol 2270. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-1237-8_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-0716-1237-8_15

  • Published:

  • Publisher Name: Humana, New York, NY

  • Print ISBN: 978-1-0716-1236-1

  • Online ISBN: 978-1-0716-1237-8

  • eBook Packages: Springer Protocols

Publish with us

Policies and ethics